11,383
Views
384
CrossRef citations to date
0
Altmetric
Research Article

Chitosan-Based Particles as Controlled Drug Delivery Systems

&
Pages 41-57 | Received 04 May 2004, Accepted 15 Jul 2004, Published online: 10 Oct 2008

REFERENCES

  • Akbuga J., Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Intl. J. Pharm. 1994; 111: 217–222
  • Alonso M. J., Calvo P., Remunan C., Jato J. L. V. Stabilization of colloidal systems by the formation of ionic lipid-polysaccharide complexes. EP 0 771 566 A1, 1997
  • Alonso M. J., Calvo P., Remunan C., Jato J. L. V. Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms. EP 0 860 166 A1, 1998
  • Artursson A., Lindmark T., Davis S. S., Illurn L. Effect of chitosan on the permeability of mono layers of intestinal epithelial cells (Caco-2). Pharm. Res. 1994; 11: 1358–1361, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Bersch P. C., Nies B., Liebendorfer A. Evaluation of the biological properties of different wound dressing materials. J. Mater. Sci. Med. 1995; 6: 231–240
  • Berthold A., Cremer K., Kreuter J. Influence of cross-linking on the acid stability and physicochemical properties of chitosan microspheres. STP Pharm. Sci. 1996; 6: 358–364
  • Berthold A., Cremer K., Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Rel. 1996a; 39: 17–25, [CROSSREF]
  • Blanco D., Alonso M. J. Development and characterization of protein-loaded poly (lactide-co-glycolide) nanospheres. Euro. J. Pharm. Biopharm. 1997; 43: 287–294, [CROSSREF]
  • Bodmeier R., Chen H., Paeratakul O. A novel approach to the delivery of microparticles or nanoparticles. Pharm. Res. 1989; 6: 413–417, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Borchard G. Chitosan for gene delivery. Adv. Drug Del. Rev. 2001; 52: 145–150, [CROSSREF]
  • Calvo P., Remunan C., Jato J. L. V., Alonso M. J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 1997; 63: 125–132, [CROSSREF]
  • Calvo P., Bougaba A., Appel M., Fattel E., Alonso M. J., Couvreur P. Oligonucleotide-chitosan nanoparticles as new gene therapy vector. Proceedings of 2nd world Meeting APGI/APV. International Association for Pharmaceutical Technology, Paris 1998
  • Carreno B. G., Duncan R. Evaluation of biological properties of soluble chitosan and chitosan microspheres. Intl. J. Pharm. 1997; 148: 231–240, [CROSSREF]
  • Chandy T., Sharma C. P. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomaterials 1992; 13: 949–952, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Chandy T., Sharma C. P. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials 1993; 14: 939–944, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Chandy T., Sharma C. P., Sunny M. C. Inhibition of platelet adhesion to glow discharge modified surfaces. J. Biomat. Appln. 1987; 1: 533–552
  • Colo G. D., Zambito Y., Burgalassi S., Serafini A., Saettone M. F. Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Intl. J. Pharm. 2002; 248: 115–122, [CROSSREF]
  • Dunn E. J., Zang X., Sun D., Goosen M. F. A. Synthesis of N-(aminoalkyl) chitosan for microcapsules. J. Appl. Polym. Sci. 1993; 50: 353–365, [CROSSREF]
  • Faldt P., Bergenstahl B., Claesson P. M. Stabilization by chitosan of soybean oil emultion coated with phospholipids and glycocholic acid. Coll. Surf. 1993; 71: 187–195, [CROSSREF]
  • Fernandez R. U., Calvo P., Jato J. R. V., Alonso M. J. Enhancement of nasal absorption of insulin using chitosan nanopartilces. Pharm. Res. 1999; 16: 1576–1581, [CROSSREF]
  • Fernandez R. U., Romani D., Calvo P., Jato J. R. V., Alonso M. J. Development of a freeze-dried formulation of insulin loaded chitosan nanoparticles intended for nasal administration. STP Pharm. Sci. 1999a; 9: 429–436
  • Florea B. I., Thanou M., Geldof M., Meaney C., Junginger H. E., Borchard G. Modified chitosan oligosaccharides as transfection agents for gene therapy of cystic fibrosis. Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Paris 2000
  • Gariepy E. R., Leclair G., Hildgen P., Gupta A., Loroux J. C. Thermosensitive chitosan based hydrogel containing liposomes for the delivery of hydrophilic molecules. J. Control. Rel. 2002; 82: 373–383, [CROSSREF]
  • Genta I., Costantini M., Asti A., Conti B., Montanari L. Influence of glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres. Carbohydrate Polym. 2000; 36: 81–88, [CROSSREF]
  • Genta I., Perugini P., Modena T., Pavanetto F., Castelli F., Muzzarelli R. A. A., Muzzarelli C., Conti B. Miconazole-loaded 6-oxychitin-chitosan microcapsules. Carbohydrate Polym. 2003; 52: 11–18, [CROSSREF]
  • Gupta K. C., Ravikumar M. N. V. Structural changes and release characteristics of cross-linked chitosan beads in response to solution pH. J. M.S. Pure and Appl.Chem. 1999; A36: 827–841, [CROSSREF]
  • Gupta K. C., Ravikumar M. N. V. Drug release behavior of beads and microgranules of chitosan. Biomaterials 2000; 21: 1115–1119, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gupta K. C., Ravikumar M. N. V. Preparation, characterization and release profiles of pH-sensitive chitosan beads. Polym. Intl. 2000a; 49: 141–146, [CROSSREF]
  • Gupta K. C., Ravikumar M. N. V. Semi-interpenetrating polymer network beads of cross-linked chitosan-glycine for controlled release of chlorphenramine maleate. J. Appl. Polym. Sci. 2000b; 76: 672–683
  • Hayashi T., Ikada Y. Protease immobilization onto porous chitosan beads. J. Appl. Polym. Sci. 1991; 42: 85–92, [CROSSREF]
  • Hejazi R., Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control. Rel. 2003; 89: 151–165, [CROSSREF]
  • Henriksen I., Smistad G., Karlsen J. Interactions between liposomes and chitosan. Intl. J. Pharm. 1994; 101: 227–236, [CROSSREF]
  • Hirano H., Seino H., Akiyama I., Nonaka I. A biocompatible material for oral and intravenous administration. Chitosan, C. G. Gebelein, R. L. Dunn. Plenum Press, New York 1990; 283–289
  • Hirano S., Seino H., Akiyama I., Nonaka I. Biocompatibility of chitosan by oral and intravenous administration. Polym. Eng. Sci. 1989; 59: 897–901
  • Holme K., Hall L. Chitosan derivatives bearing C10 alkyl glycosides branches: A temperature induced gelling polysaccharide. Macromolecules 1991; 24: 3828–3833
  • Hornof M. D., Kast C. E., Schnurch A. B. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Euro. J. Pharm. and Biopharm. 2003; 55: 185–190, [CROSSREF]
  • Hu Y., Jiang X., Ding Y., Ge H., Yuan Y., Yang C. Synthesis and characterization of chitosan-poly (acrylic acid) nanoparticles. Biomaterials 2002; 23: 3193–3201, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hughes R. C. The complex carbohydrates of mammalian cell surfaces and their biological roles. Essays Biochem. 1975; 11: 1–36, [PUBMED], [INFOTRIEVE]
  • Huguet M. L., Dellacherie E. Calcium alginate beads coated with chitosan, effect of structure encapsulated materials on their release. Process Biochem. 1996; 31: 745–751, [CROSSREF]
  • Huguet M. L., Groboillot A., Neufeld R. J., Poncelet D., Dellacherie E. Hemoglobin encapsulation in chitosan/calcium alginate beads. J. Appl. Polym. Sci. 1994; 51: 1427–1432, [CROSSREF]
  • Huguet M. L., Neufeld R. J., Dellacherie E. Calcium alginate beads coated with polycationic polymers: comparison of chitosan and DEAE-dextran. Process Biochem. 1996a; 31: 347–353, [CROSSREF]
  • Ida G., Monica C., Annalia A., Bice C., Luisa M. Influence of glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres. Carbohydrate Polym. 1998; 36: 81–88, [CROSSREF]
  • Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998; 15: 1326–1331, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Illum L., Farraj N. F., Davis S. S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 1994; 11: 1186–1189, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Janes K. A., Calvo P., Alonso M. J. Polysaccharide colloidal partilce as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001; 47: 83–97, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Janes K. A., Fresneau M. P., Marazuela A., Fabra A., Alonso M. J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Rel. 2001a; 73: 255–267, [CROSSREF]
  • Kadiyala I., Roy K., Rice J., Leong K. W. Transport kinetics of DNA nanopartilces in a Caco-2-peyer's patch model of intestinal epithelium. Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Paris 2000
  • Kast C. E., Schnurch A. B. Thiolated polymers- thiomers, development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 2001; 22: 2345–2352, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kato Y., Onishi H., Machida M. A novel water-soluble N-succinyl chitosan-mitomycin C conjugate prepared by direct carbodiimide coupling: physicochemical properties, antitumor characteristics and systemic retention. STP Pharm. Sci. 2000; 10: 133–142
  • Kerneis S., Bogdanova A., Kraehenbuhl J. P., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997; 277: 949–952, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Knapczyk J., Kroweczynski L., Krzck J., Brzeski M., Nirnberg E., Schenk D., Struszcyk H. Chitin and chitosan: source, chemistry, biochemistry, physical properties and applications. Requirements of Chitosan for Pharmaceutical and Biomedical Applications, G. Shak, T. Anthonsen, P. Sandford. Elsevier, London 1989; 657–663
  • Koga D. Chitin enzymology-chitinase. Adv. Chitin Sci. 1998; 3: 16–23
  • Kokufuta E., Zhang Y. Q., Tanaka T. Saccharide sensitive phase transition of a lectin-loaded gel. Nature 1991; 351: 302–304, [CROSSREF]
  • Kopecek J., Vacik J., Lim D. Permeability of membranes containing ionogenic group. J. Polym. Sci. 1971; 9: 2801–2815
  • Kurisawa M., Matsuo Y., Yui N. Modulated degradation of hydrogels with thermo-responsive network in relation to their swelling behavior. Macromol. Chem. Phys. 1998; 199: 705–709
  • Lee K. Y., Kwon I. C., Kim Y. H., Jo W. H., Jeong S. Y. Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Rel. 1998; 51: 213–220, [CROSSREF]
  • Lee K. Y., Park W. H., Ha W. S. Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives. J. Appl. Polym. Sci. 1997; 63: 425–432, [CROSSREF]
  • Lee Y. M., Shin E. M. Pervaporation separation of water-ethanol through modified chitosan membranes, IV. Phosphorylated chitosan membranes. J. Membrane Sci. 1991; 64: 145–152
  • Lehr C. M., Bowstra J. A., Schacht E. H., Jungiger H. E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Intl. J. Pharm. 1992; 78: 43–48
  • Leong K. W., Mao H. Q., Truong V. L., Roy K., Walsh S. M., August J. T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Rel. 1998; 53: 183–193, [CROSSREF]
  • Lorenzo M. L., Remunan C. L., Jato J. L. V., Alonso M. J. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Rel. 1998; 52: 109–118, [CROSSREF]
  • Lubben I. M. V. D., Verhoef J. C., Borchard G., Junginger H. E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Euro. J. Pharm. Sci. 2001; 14: 201–207, [CROSSREF]
  • Lueben H. L., Leeuw B. J. D., Langemeyer B. W., Boer A. G. D., Verhoef J. C., Junginger H. E. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide buserelin in vivo. Pharm. Res. 1996; 13: 1668–1672, [CROSSREF]
  • Mao H. Q., Roy K., Truong V. L., August J. T., Leong K. W. DNA-chitosan nanospheres, derivitization and storage stability. Proceedings of 24th International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Stockholm 1997
  • Mao H. Q., Roy K., Walsh S. M., August J. T., Leong K. W. DNA-chitosan nanoparticles for gene delivery. Proceedings of 23rd International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Kyoto 1996
  • Martin L., Wilson C. G., Koosha F., Tetley L., Gray A. I., Senel S., Uchegbu I. F. The release of model macromolecules controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. J. Control. Rel. 2002; 80: 87–91, [CROSSREF]
  • Mi F. L., Shyu S. S., Chen C. T., Schoung J. Y. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release. Biomaterials 1999; 20: 1603–1612, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Mi F. L., Sung H. W., Shyu S. S. Synthesis and charecterization of a novel chitosan.based network prepared using naturally occuring crosslinker. J. Polym. Sci. Part A: Polym. Chem. 2000; 38: 2804–2814
  • Mi F. L., Tan Y. C., Liang H. F., Sung H. W. In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 2002; 23: 181–191, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Miwa A., Ishibe A., Nakano M., Yamahira T., Itai S., Jinno S., Kawahara H. Development of novel chitosan derivatives as micellar carriers of taxol. Pharm. Res. 1998; 15: 1844–1850, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Mumper R. J., Wang J., Claspell J. M., Rolland A. P. Novel polymeric condensing carriers for gene delivery. Proceedings of 22nd International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Washington 1995
  • Murata J., Ohya Y., Ouchi T. Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool. Carbohydrate Polymers 1997; 32: 105–109, [CROSSREF]
  • Muzzarelli R. Natural chelating polymers. Chitosan, R. Muzzarelli. Pergamon Press, Oxford 1973; 144–176
  • Muzzarelli R. A. A. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol. Life Sci. 1997; 53: 131–140, [PUBMED], [INFOTRIEVE]
  • Nishimura K., Nishimura S., Seo H., Nishi N., Tokura S., Azuma I. Macrophage activation with multiporous beads prepared from partially deacetylated chitin. J. Biomed. Mater. Res. 1986; 20: 1359–1372, [PUBMED], [INFOTRIEVE]
  • Nishimura S., Miyura Y., Ren L., Sato M., Yamagishi A., Nishi N., Tokura S., Kurita K., Ishii S. An efficient method for the synthesis of novel amphiphilic polysaccharide by region and thermo selective modifications of chitosan. Chemistry letters 1993; 1623–1626
  • Ohya Y., Shiratani M., Kobayashi H., Ouchi T. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl. Chem. 1994; A31: 629–642
  • Okoli G., Hortelano G., Leong K. W. Oral delivery of plasmid DNA encoding the factor IX gene. Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Paris 2000
  • Olson R., Schwartzmiller D., Weppner W., Winandy R. Chitin and chitosan sources, chemistry, biochemistry, physical properties and applications. Biomedical Application of Chitin and its Derivatives, G. S. Braek, T. Antonsen, P. Sandford. Elsevier, London 1988; 813–828
  • Onishi H., Nagai T., Machida Y. Applications of chitin and chitosan. Application of Chitin, Chitosan, and their Derivatives to Drug Carriers for Microparticulated or Conjugated Drug Delivery System, M. F. A. Goosen. Technomic Publishing Co., Lancaster 1997; 205–231
  • Onishi H., Takahashi H., Yoshiyasu M., Machida Y., Nagai T. Macromolecular prodrugs of cytarabine and mitomycin C with chitosan, N-succinyl chitosan and 6-O-carboxymethyl-chitin as drug carriers. Chitin World, L. S. Karnicki, M. M. Brzeski, P. J. Bykowski, A. P. Wojtasz. Bremerhaven, Wirtchaftsverlag, NW 1994; 301–310
  • Onishi H., Takahashi T., Yoshiyasu M., Machida Y. Preparation and in vitro properties of N-succinyl chitosan or carboxyl methyl chitin- mitomycin C conjugates microparticles with specified size. Drug. Dev. Ind. Pharm. 2001; 27: 659–667, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Park Y. K., Park Y. H., Shin B. A., Choi E. S., Park Y. R., Akaike T., Cho C. S. Galactosylated chitosan-graft-dextran as hepatocyte targeting DNA carrier. J. Control. Rel. 2000; 69: 97–108, [CROSSREF]
  • Peppas N. A. Hydrogels and drug delivery. Curr. Opin. Coll. Inter. Sci. 1997; 2: 531–537
  • Ramos V. M., Rodriguez N. M., Rodriguez M. S., Heras A., Agullo E. Modified chitosan carrying phosphonic and alkyl groups. Carbohydrate Polymers. 2003; 51: 425–429, [CROSSREF]
  • Ravikumar M. N. V., Kumar N. Polymeric controlled drug delivery systems: perspective issues and opportunities. Drug Devel. Ind. Pharm. 2001; 27: 1–18, [CROSSREF]
  • Roldo M., Hornof M., Caliceti P., Schnurch A. B. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Euro. J. Pharm. Biopharm. 2004; 57: 115–121, [CROSSREF]
  • Roy K., Mao H. Q., Huang S. K., Leong K. W. Oral gene delivery with chitosan-DNA nanopartilces generates immunologic protection in a murine model of peanut allergy. Nature Med. 1999; 5: 387–391, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Roy K., Mao H. Q., Leong K. W. DNA-chitosan nanospheres, transfection efficiency and cellular uptake. Proceedings of 24th International Symposium on Controlled Rellease of Bioactive Materials. Controlled Release Society, Stockholm 1997
  • Sato M., Onishi H., Machida M., Nagai T. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and n-succinyl chitosan. Biol. Pharm. Bull. 1996; 19: 241–245, [PUBMED], [INFOTRIEVE]
  • Sato M., Onishi H., Takahara J., Machida Y., Nagai T. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan. Biol. Pharm. Bull. 1996a; 19: 1170–1177, [PUBMED], [INFOTRIEVE]
  • Sato T., Shirakawa N., Nishi H., Okahata Y. Formation of a DNA/polygalactosamine complex and its interaction with cells. Chem. Lett. 1996b; 9: 725–726
  • Schipper N. G. M., Hoogstraate J. A., Boer A. G. D., Varum K. M., Artursson P. Chitosan as absorption enhancers for poorly absorbable drugs. 2. Mechanism of absorption enhancement. Pharm. Res. 1997; 14: 923–929, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Schnurch A. B., Guggi D., Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Rel. 2004; 94: 177–186, [CROSSREF]
  • Schnurch A. B., Hornof M., Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Intl. J. Pharm. 2003; 260: 229–237, [CROSSREF]
  • Shantha K. L., Harding D. R. K. Preparation and in vitro evaluation of poly(N-vinyl-2-pyrrolidone-polyethylene glycol diacrylate)-chitosan interpolymeric pH-responsive hydrogels for oral drug delivery. Intl. J. Pharm. 2000; 207: 65–70, [CROSSREF]
  • Sheehan J. C., Hlavka J. J. The use of water-soluble and basic carbodiimides in peptide synthesis. J. Org. Chem. 1956; 21: 439–441
  • Shirahata K. Mitomycin basic studies. Derivatives and Activities, T. Taguchi. Kyowa Kikaku Tsushin, Tokyo 1984; 25–43
  • Shu X. Z., Zhu K. J. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Euro. J. Pharm. Biopharm. 2002; 54: 235–243, [CROSSREF]
  • Sinha V. R., Singla A. K., Wadhawan S., Kaushik R., Kumria R., Bansal K., Dhawan S. Chitosan microspheres as a potential carrier for drugs. Intl. J. Pharm. 2004; 274: 1–33, [CROSSREF]
  • Song Y., Onishi H., Machida Y. Synthesis and drug release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethy-chitin. Chem. Pharm. Bull. 1992; 40: 2822–2825, [PUBMED], [INFOTRIEVE]
  • Song Y., Onishi H., Machida Y., Nagai T. Particle characteristics of carboxymethyl chitin–mitomycin C conjugate and their distribution and histological effect on some tissues after intravenous administration. STP Pharm. Sci. 1995; 5: 162–170
  • Song Y., Onishi H., Machida Y., Nagai T. Drug release and antitumor characteristics of N-succinyl chitosan-mitomycin C as an implant. J. Control. Rel. 1996; 42: 93–100, [CROSSREF]
  • Surini S., Akiyama H., Morishita M., Nagai T., Takayama K. Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate. J. Control. Rel. 2003; 90: 291–301, [CROSSREF]
  • Suzuki A., Tanaka T. Phase transition in polymer gels induced by visible light. Nature 1990; 346: 345–347, [CROSSREF]
  • Tien C. L., Lacroix M., Szabo P. I., Mateescu M. A. N-acylated chitosan: hydrophobic matrices for controlled drug release. J.Control. Rel. 2003; 93: 1–13, [CROSSREF]
  • Tobio M., Gref R., Sanchez A., Langer R., Alonsa M. J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 1998; 15: 270–275, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Tobio M., Sanchez A., Vila A., Soriano I., Evora C., Jato J. L. V. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles. Coll. Surf. Biointerf. 2000; 18: 315–323, [CROSSREF]
  • Torrado S., Prada P., Torre P. M., Torrado S. Chitosan-poly(acrylic)acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 2004; 25: 917–923, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Tozaki H., Fujita T., Odoriba T., Terabe A., Suzuki T., Tanaka C., Okabe S., Muranishi S. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using using chitosan capsules, therapeutic effects against 2,4,6-trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. Life Sci. 1999; 64: 1155–1162, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S. Chitosan capsules for colon-specific drug delivery, improvement of insulin absorption from the rat colon. J. Pharm. Sci. 1997; 86: 1016–1021, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Uchegbu I. F., Sadiq L., Arastoo M., Gray A. I., Wang W., Waigh R. D., Schatzleina A. G. Quaternary ammonium palmitoyl glycol chitosan—a new polysoap for drug delivery. Intl. J. Pharm. 2001; 224: 185–189, [CROSSREF]
  • Urrusuno R. F., Calvo P., Lopez C. R., Jato J. L. V., Alonso M. J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 1999; 16: 1576–1581, [CROSSREF]
  • Vila A., Sanchez A., Tobio M., Calvo P., Alonso M. J. Design of biodegradable particles for protein delivery. J. Control. Rel. 2002; 78: 15–24, [CROSSREF]
  • Watzke H. J., Dieschbourg C. Novel silica-biopolymer nanocomposites: the silica sol-gel process in biopolymer organogels. Adv. Coll. Interfac. Sci. 1994; 50: 1–14, [CROSSREF]
  • Weiner M. L. An overview of the regulatory status and of the safety of chitin and chitosan as food and pharmaceutical ingredients. Advances in Chitin and Chitosan, C. J. Brine, P. A. Sanford, J. P. Zikakis. Elsevier, London 1992; 670–678
  • Williams R. O., Barron M. K., Alonso M. J., Remunan C. L. Investigation of a Pmdi system containing chitosan microspheres and p134a. Intl. Pharm. 1998; 174: 209–222, [CROSSREF]
  • Win P. P., Ya Y. S., Hong K. J., Kajiuchi T. Formulation and charecterization of pH sensitive drug carrier based on phosphorylated chitosan. Carbohydrate Polym. 2003; 53: 305–310, [CROSSREF]
  • Yamaguchi R., Arai Y., Itoh T., Hirano S. Preparation of partially N-succinylated chitosans and their cross-linked gels. Carbo. Res. 1981; 15: 172–175, [CROSSREF]
  • Yamamoto A., Tozaki H., Okada N., Fujita T. Colon-specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules. STP Pharm. Sci. 2000; 10: 23–34
  • Yao K., Peng T., Xu M., Yuan C. pH-dependent hydrolysis and drug release of chitosan/polyether interpenetrating polymer network hydrogel. Polym. Intl. 1994; 34: 213–219
  • Yao K. D., Peng T., Yu J. J., Xu M. X., Goosen M. F. A. Microcapsules/Microspheres related to chitosan. Rev. Macromol. Chem. Phys. 1995; C35: 155–180
  • Yin Y., Xu M., Chen X., Yao K. D. Drug release behavior of chitosan/gelatine network polymer microspheres. Chinese Sci. Bull. 1996; 41: 1266–1270
  • Yoshioka H., Nonaka K., Fukada K., Kazama S. Chitosan derived polymer surfactants and their micellar properties. Biosci. Biotech. Biochem. 1995; 59: 1901–1904
  • Zenke M., Steinlein P., Wagner E., Cotton M., Beug H., Birnstiel M. L. Receptor-mediated endocytosis of transferring-poly cation conjugates, an efficient to introduce DNA into hematopoietic cells. Proceedings of the 87th National Academy of Sciences. National Academy of Sciences, Washington 1990

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.